Charles River Laboratories International Stock Price. Everything You Need To Know About The Charles River Laboratories International Stock!

Charles River Laboratories International, Inc. is a leading early-stage contract research company headquartered in Wilmington, Massachusetts. With a team of 20,000 full-time employees, the company provides research models that are essential in the development of new drugs, devices, and therapies.

If you’re interested in the stock market, you’ll be pleased to know that Charles River Laboratories International, Inc. is a publicly-traded company with a solid stock price. For investors, it’s important to note that the premarket stock price today has remained steady, signaling a strong financial performance and market position.

The firm operates through three primary segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. The RMS segment offers a range of research models, research model services, and research and cells solutions businesses. Meanwhile, the DSA segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs. This includes therapeutic discovery and optimization, as well as in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. Finally, the Manufacturing segment includes Microbial Solutions and Biologics Solutions, providing advanced manufacturing solutions to customers.

Since its IPO on 2000-06-23, Charles River Laboratories International, Inc. has solidified its position as a leading player in the contract research space. With a focus on innovation and delivering high-quality services, the company is well-positioned for continued growth and success.